SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why? -- Ignore unavailable to you. Want to Upgrade?


To: Douglas who wrote (301)11/20/1997 12:04:00 PM
From: Douglas  Respond to of 455
 
The National Institutes of Health is outlining the 21st century agenda for women's health at this week's conference entitled: "Beyond Hunt Valley: Research on Women's Health for the 21st Century." This meeting is a follow-up to the 1991 conference held in Hunt Valley, MD.

Representative Constance A. Morella was a speaker at this conference. Reuters said "Representative Morella called for more research to combat sexually transmitted diseases. Each year 12 million STD cases are reported in the United States. Twenty-five percent of those are among teenagers, translating into a rate of 1 in 8 teens infected with STD. Those are only the reported cases, said Morella. Health experts estimate that about 1 in 4 sexually active teens become infected. The gonorrhea rates in this country approximate those in the developing world, and infection with human papilloma virus (HPV) is the single most important risk factor for invasive cervical cancer, said Representative Morella. It's essential that we develop MICROBICIDAL PRODUCTS, products to prevent transmissions of STD's with an emphasis on methods that women can AFFORD and CONTROL WITHOUT THE KNOWLEDGE OF THEIR PARTNERS, said Morella, who is also pushing legislation for more HIV research for women."



To: Douglas who wrote (301)11/20/1997 6:16:00 PM
From: Daniel Shaffer  Read Replies (2) | Respond to of 455
 
No Trading Since 11/11?

Thanks, Douglas, for your information re:

".....the issuance of up to a maximum of 200 units to investors
in a private placement, with each unit consisting of 1,000 shares of
Series B Convertible Preferred Stock and warrants to purchase 333,333
shares of common stock."

Do you know how (a) how much each unit is to be sold for and (b)
what the price for common stock would be if the warrants are
exercised? Are the terms of a private placement for a public
company public?

Also, when I checked PC Quote today, it showed no trading in
PRCTD since November 11--over a week ago. This seems strange.
Have they changed their symbol again? I will check some other
quote sites to see if they show any trading.

Thanks for the information update re. the potential increase in
interest in/need for products like those PRCTD is developing.

PS: Are we the last two people in Cyberspace following this stock?